Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05845333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor 2 versions Re-verified since Mar 12, 2024, no change to tracked fieldsv2-v3
  2. Minor Study First Submitted
Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.
Trial Details
NCT Number NCT05845333
Lead Sponsor The Mind Research Network
Conditions
(from sponsor)
Stimulant Abuse, Criminal Behavior
Related terms Criminal Behavior
Enrollment 334 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov